Sanofi Consumer Healthcare India Ltd - Financial Result for the Quarter ended 30th Sep'26
Sanofi Consumer Healthcare India Ltd · Outcome · 28 Oct 2026, 11:51 pm
Sanofi Consumer Healthcare India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million) ■ Revenue: 2,631 (+12.5% YoY | +11.6% QoQ) ■ EBITDA: 1,017 (+19.6% YoY | +13.9% QoQ) ■ EBITDA Margin (%): 38.7 (+231 bps YoY | +77 bps QoQ) ■ PAT: 766 (+21.8% YoY | +11.3% QoQ) ■ EPS (INR): 33.3 (+21.8% YoY | +11.3% QoQ)
Original exchange filing (PDF)
More announcements from Sanofi Consumer Healthcare India Ltd
- Sanofi Consumer Healthcare India Limited has informed the Exchange regarding a press release dated October 28, 2026. · 29 Oct 2026
- The Board of Directors at its meeting held on Wednesday, 28th October 2026, considered and approved the Unaudited Financial Results for the quarter and nine months ended 30th September .... · 29 Oct 2026
- Sanofi Consumer Healthcare India Limited has submitted to the Exchange, the Unaudited Financial Results for the quarter and nine months ended September 30, 2026. · 29 Oct 2026
- Unaudited Financial Results for the quarter and nine months ended September 30, 2026 is enclosed. · 29 Oct 2026
- Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 28 Oct 2026
- Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve the Unaudited .... · 28 Oct 2026
- Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 28 Oct 2026
- To consider and approve the Unaudited Financial Results for the quarter and nine months ended September 30, 2026 · 28 Oct 2026
